Blood Velocity Variation in Right Renal and Superior Mesenteric Arteries During Cardio-pulmonary Bypass
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
The cardiopulmonary by-pass (CPB) technique, used in cardiac surgery to obtain a bloodless operating field and an immobile heart, determines important effects on the blood vessel wall, especially when a continuous and non-continuous blood flow is used. In fact, a reduction in NO production by the endothelium, an increase in systemic vascular resistance and an increased risk of cerebral and renal hypoperfusion have been observed and can result in potential organ damage.
Acute kidney injury (AKI) after heart surgery is a major cause of mortality and morbidity. Its incidence varies according to different definitions, but can reach 30%. In some series, 1-5% of patients require renal replacement therapy (RRT) in the postoperative period presenting a mortality that can reach 50-70%. However, even more limited increases in serum creatinine (sCr) are associated with worsening prognosis and the risk of chronic kidney disease (CKD). The pathophysiology of AKI in cardiac surgery is complex and still partly unknown. It is believed that one of the main causative factors is hypoperfusion and renal hypoxia, in particular of the medullary region; this would result in a vasoconstriction of the afferent arterioles to the glomerulus and a reduction in filtration. Risk factors associated with the increased incidence of AKI include bleeding, use of the aortic pump, excessive cardiopulmonary bypass duration, excessive haemodilution, insufficient pump flow, or insufficient blood pressure. Hypothermia, which also has a protective effect against hypoperfusion and tissue hypoxia, could induce AKI by increasing renal vascular resistance and favoring medullary hypoxia during subsequent rewarming.
In addition to AKI, another complication of cardiac surgery, rarer but associated with a higher mortality, is acute mesenteric ischemia; the most frequent type is non-occlusive mesenteric ischemia (NOMI) which seems to have as a predisposing cause a reduction or maldistribution of splanchnic blood flow and the use of vasoconstrictors.
Recently a technique has been described that allows to measure the blood velocity in the right renal artery and in the superior mesenteric artery using the transesophageal echocardiogram (TEE); this technique allows to view these arteries and measure the speed of the blood with good precision because the insonation angle (ie the angle formed by the ultrasound flow and the direction of the blood vessel) is adequate. In cardiac surgery, this methodology allows you to monitor blood velocity in the right renal artery and superior mesenteric artery during surgery. Some authors have used it to conduct pilot studies in which the blood velocity values in the renal arteries during cardiac surgery were used to calculate the pulsatility and resistivity indices, as predictors of the risk of postoperative AKI. The calculation of these indices, however, requires the use of a pulsatile blood flow to generate a periodic variation of the blood velocity, and they are not evaluable during CPB since the current practice in almost all centers is to use a continuous blood flow. At present, therefore, despite the fact that TEE is routinely used for monitoring renal perfusion during cardiac surgery, the blood velocity in the renal and mesenteric arteries has been little studied during CPB and has never been evaluated during CPB with continuous flow; in particular, the possible variation in blood velocity measured during CPB compared to the baseline values measured before extracorporeal circulation and its correlation with the onset of postoperative renal failure is not known.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Gabriella Arlotta, M.D.
- Phone Number: +390630154848
- Email: g.arlotta72@gmail.com
Study Contact Backup
- Name: Temistocle Taccheri, M.D.
- Phone Number: +390630154848
- Email: taccheri.temistocle@gmail.com
Study Locations
-
-
-
Roma, Italy, 00168
- Recruiting
- Fondazione Policlinico Universitario A,Gemelli IRCCS
-
Contact:
- Gabriella Arlotta, MD
- Phone Number: +390630154848
- Email: gabriella.arlotta@policlinicogemelli.it
-
Contact:
- Temistocle Taccheri
- Phone Number: +390630154848
- Email: temistocle.taccheri@policlinicogemelli.it
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- age> 18 years
- written informed consent
- cardiac surgery with cardiopulmonary bypass (CPB)
- New York Heart Association (NYHA) class I, II, III
- preoperative serum creatinine less than 1.2 mg / dl
Exclusion Criteria:
- contraindications to Trans Esophageal Ultrasound (TEE) based on American Society of Anesthesiologists (ASA) recommendations (esophageal or gastric diseases or previous surgery)
- history of non-coronary arterial pathologies
- atrial fibrillation
- preoperative serum creatinine greater than 1.2 mg / dl • NYHA class IV
- emergency cardiac surgery
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Heart Surgical Patients
Patients with cardiovascular disease, who must undergo cardiac surgery in extracorporeal circulation with continuous flow
|
To measure mean blood velocity at the level of the right renal and superior mesenteric artery
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of right renal artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: Basal 1: up to 10 minutes after induction of anesthesia and placement of transesophageal probe
|
Right renal artery mean blood velocity (cm/sec) before CPB
|
Basal 1: up to 10 minutes after induction of anesthesia and placement of transesophageal probe
|
|
Comparison of right renal artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: Basal 2: up to 30 minutes after sternotomy in conditions of hemodynamic stability
|
Right renal artery mean blood velocity (cm/sec) before CPB
|
Basal 2: up to 30 minutes after sternotomy in conditions of hemodynamic stability
|
|
Comparison of right renal artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: CPB 5 min: during CPB, 5 minutes after the end of the first cardioplegia
|
Right renal artery mean blood velocity (cm/sec) during CPB
|
CPB 5 min: during CPB, 5 minutes after the end of the first cardioplegia
|
|
Comparison of right renal artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: CPB 30 min: during CPB, 30 minutes after the end of the first cardioplegia
|
Right renal artery mean blood velocity (cm/sec) during CPB
|
CPB 30 min: during CPB, 30 minutes after the end of the first cardioplegia
|
|
Comparison of right renal artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
|
Right renal artery mean blood velocity (cm/sec) during CPB
|
CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of superior mesenteric artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: Basal 1: up to 10 minutes after induction of anesthesia and placement of transesophageal probe
|
Superior mesenteric artery mean blood velocity (cm/sec) before CPB
|
Basal 1: up to 10 minutes after induction of anesthesia and placement of transesophageal probe
|
|
Comparison of superior mesenteric artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: Basal 2: up to 30 minutes after sternotomy in conditions of hemodynamic stability
|
Superior mesenteric artery mean blood velocity (cm/sec) before CPB
|
Basal 2: up to 30 minutes after sternotomy in conditions of hemodynamic stability
|
|
Comparison of superior mesenteric artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: CPB 5 min: during CPB, 5 minutes after the end of the first cardioplegia
|
Superior mesenteric artery mean blood velocity (cm/sec) during CPB
|
CPB 5 min: during CPB, 5 minutes after the end of the first cardioplegia
|
|
Comparison of superior mesenteric artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: CPB 30 min: during CPB, 30 minutes after the end of the first cardioplegia
|
Superior mesenteric artery mean blood velocity (cm/sec) during CPB
|
CPB 30 min: during CPB, 30 minutes after the end of the first cardioplegia
|
|
Comparison of superior mesenteric artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
|
Superior mesenteric artery mean blood velocity (cm/sec) during CPB
|
CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
|
|
Correlation between mean blood velocity values and hemodynamic parameters: cardiopulmonary by-pass (CPB) blood flow
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
Correlation between right renal artery mean blood velocity (cm/sec) and CPB blood flow (L/min)
|
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
|
Correlation between mean blood velocity values and CPB blood flow
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia, during CPB
|
Correlation between right renal artery mean blood velocity (cm/sec) and CPB blood flow (L/min)
|
CPB 30 min: 30 minutes after the end of the first cardioplegia, during CPB
|
|
Correlation between right renal artery mean blood velocity values and CPB blood flow
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
|
Correlation between right renal artery mean blood velocity (cm/sec) and cardiopulmonary by-pass blood flow (L/min)
|
CPB 60 min: 60 minutes after the end of the first cardioplegia
|
|
Correlation between superior mesenteric artery mean blood velocity values and cardiopulmonary by-pass (CPB) blood flow
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and cardiopulmonary by-pass blood flow (L/min)
|
CPB 5 min: 5 minutes after the end of the first cardioplegia
|
|
Correlation between superior mesenteric artery mean blood velocity values and CPB blood flow
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia, during cardiopulmonary by-pass
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and cardiopulmonary by-pass blood flow (L/min)
|
CPB 30 min: 30 minutes after the end of the first cardioplegia, during cardiopulmonary by-pass
|
|
Correlation between superior mesenteric artery mean blood velocity values and CPB blood flow
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and cardiopulmonary by-pass blood flow (L/min)
|
CPB 60 min: 60 minutes after the end of the first cardioplegia
|
|
Correlation between right renal artery mean blood velocity values and hemodynamic parameters (mean arterial pressure, MAP)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia
|
Correlation between right renal artery mean blood velocity (cm/sec) and mean arterial pressure (mmHg)
|
CPB 5 min: 5 minutes after the end of the first cardioplegia
|
|
Correlation between right renal artery mean blood velocity values and MAP
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
|
Correlation between right renal artery mean blood velocity (cm/sec) and MAP (mmHg)
|
CPB 30 min: 30 minutes after the end of the first cardioplegia
|
|
Correlation between right renal artery mean blood velocity values and MAP
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
|
Correlation between right arterial mean blood velocity (cm/sec) and mean arterial pressure (mmHg)
|
CPB 60 min: 60 minutes after the end of the first cardioplegia
|
|
Correlation between superior mesenteric artery mean blood velocity values and hemodynamic parameters (mean arterial pressure, MAP)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and MAP (mmHg)
|
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
|
Correlation between superior mesenteric artery mean blood velocity values and MAP
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and mean arterial pressure (mmHg)
|
CPB 30 min: 30 minutes after the end of the first cardioplegia
|
|
Correlation between superior mesenteric artery mean blood velocity values and MAP
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and MAP (mmHg)
|
CPB 60 min: 60 minutes after the end of the first cardioplegia
|
|
Correlation between right renal artery mean blood velocity values and laboratory parameters (arterial PCO2)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
Correlation between right renal artery mean blood velocity (cm/sec) and arterial PCO2 (mmHg)
|
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
|
Correlation between right renal artery mean blood velocity values and laboratory parameters (arterial PCO2)
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
|
Correlation between right renal artery mean blood velocity (cm/sec) and arterial PCO2 (mmHg)
|
CPB 30 min: 30 minutes after the end of the first cardioplegia
|
|
Correlation between right renal artery mean blood velocity values and arterial PCO2
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
|
Correlation between right renal artery mean blood velocity (cm/sec) and arterial PCO2 (mmHg)
|
CPB 60 min: 60 minutes after the end of the first cardioplegia
|
|
Correlation between superior mesenteric artery mean blood velocity values and laboratory parameters (arterial PCO2)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and arterial PCO2 (mmHg)
|
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
|
Correlation between superior mesenteric artery mean blood velocity values and laboratory parameters (arterial PCO2)
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and arterial PCO2 (mmHg)
|
CPB 30 min: 30 minutes after the end of the first cardioplegia
|
|
Correlation between superior mesenteric artery mean blood velocity values and arterial PCO2
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and arterial PCO2 (mmHg)
|
CPB 60 min: 60 minutes after the end of the first cardioplegia
|
|
Correlation between right renal artery mean mean blood velocity values and laboratory parameters (Hematocrit)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
Correlation between right renal artery mean blood velocity (cm/sec) and hematocrit
|
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
|
Correlation between right renal artery mean mean blood velocity values and laboratory parameters (Hematocrit)
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
|
Correlation between right renal artery mean blood velocity (cm/sec) and hematocrit
|
CPB 30 min: 30 minutes after the end of the first cardioplegia
|
|
Correlation between right renal artery mean mean blood velocity values and laboratory parameters (Hematocrit)
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
|
Correlation between right renal artery mean blood velocity (cm/sec) and hematocrit
|
CPB 60 min: 60 minutes after the end of the first cardioplegia
|
|
Correlation between superior mesenteric artery mean mean blood velocity values and laboratory parameters (Hematocrit)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and hematocrit
|
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
|
Correlation between superior mesenteric artery mean mean blood velocity values and Hematocrit
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and hematocrit
|
CPB 30 min: 30 minutes after the end of the first cardioplegia
|
|
Correlation between superior mesenteric artery mean mean blood velocity values and Hematocrit
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and hematocrit
|
CPB 60 min: 60 minutes after the end of the first cardioplegia
|
|
Correlation between right renal artery mean blood velocity values and Temperature
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
Correlation between right renal artery mean blood velocity (cm/sec) and Temperature (Celsius degrees)
|
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
|
Correlation between right renal artery mean blood velocity values and Temperature
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
|
Correlation between right renal artery mean blood velocity (cm/sec) and Temperature (Celsius degrees)
|
CPB 30 min: 30 minutes after the end of the first cardioplegia
|
|
Correlation between right renal artery mean blood velocity values and Temperature
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
|
Correlation between right renal artery mean blood velocity (cm/sec) and Temperature (Celsius degrees)
|
CPB 60 min: 60 minutes after the end of the first cardioplegia
|
|
Correlation between superior mesenteric artery mean blood velocity values and Temperature
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and Temperature (Celsius degrees)
|
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
|
Correlation between superior mesenteric artery mean blood velocity values and Temperature
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and Temperature (Celsius degrees)
|
CPB 30 min: 30 minutes after the end of the first cardioplegia
|
|
Correlation between superior mesenteric artery mean blood velocity values and Temperature
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and Temperature (Celsius degrees9
|
CPB 60 min: 60 minutes after the end of the first cardioplegia
|
|
Correlation between right renal artery mean blood velocity values and negative pressure applied to the venous drainage (vacuum-assist venous drainage, VAVD)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
Correlation between right renal artery mean blood velocity (cm/sec) and negative pressure applied to the venous drainage (vacuum-assist venous drainage) (mmHg)
|
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
|
Correlation between right renal artery mean blood velocity values and negative pressure applied to the venous drainage (vacuum-assist venous drainage, VAVD)
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
|
Correlation between right renal artery mean blood velocity (cm/sec) and VAVD (mmHg)
|
CPB 30 min: 30 minutes after the end of the first cardioplegia
|
|
Correlation between right renal artery mean blood velocity values and negative pressure applied to the venous drainage (vacuum-assist venous drainage, VAVD)
Time Frame: CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
|
Correlation between right renal artery mean blood velocity (cm/sec) and VAVD (mmHg)
|
CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
|
|
Correlation between superior mesenteric artery mean blood velocity values and negative pressure applied to the venous drainage (vacuum-assist venous drainage, VAVD)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
Correlation between superior mesenteric artery mean blood velocity values and negative pressure applied to the venous drainage (vacuum-assist venous drainage, VAVD) (mmHg)
|
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
|
Correlation between superior mesenteric artery mean blood velocity values and negative pressure applied to the venous drainage (vacuum-assist venous drainage, VAVD)
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
|
Correlation between superior mesenteric artery mean blood velocity values and negative pressure applied to the venous drainage (vacuum-assist venous drainage, VAVD) (mmHg)
|
CPB 30 min: 30 minutes after the end of the first cardioplegia
|
|
Correlation between superior mesenteric artery mean blood velocity values and negative pressure applied to the venous drainage (vacuum-assist venous drainage, VAVD)
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
|
Correlation between superior mesenteric artery mean blood velocity values and VAVD (mmHg)
|
CPB 60 min: 60 minutes after the end of the first cardioplegia
|
|
Correlation between right renal artery mean blood velocity values and laboratory parameters (arterial lactate)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
Correlation between right renal artery mean blood velocity (cm/sec) and arterial lactate (mmol/L)
|
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
|
|
Correlation between right renal artery mean blood velocity values and laboratory parameters (arterial lactate)
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
|
Correlation between right renal artery mean blood velocity (cm/sec) and arterial lactate (mmol/L)
|
CPB 30 min: 30 minutes after the end of the first cardioplegia
|
|
Correlation between right renal artery mean blood velocity values and laboratory parameters (arterial lactate)
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
|
Correlation between right renal artery mean blood velocity (cm/sec) and arterial lactate (mmol/L)
|
CPB 60 min: 60 minutes after the end of the first cardioplegia
|
|
Correlation between superior mesenteric artery mean blood velocity and laboratory parameters (arterial lactate)
Time Frame: CPB 5 min: during CPB, 5 minutes after the end of the first cardioplegia
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and arterial lactate (mmol/L)
|
CPB 5 min: during CPB, 5 minutes after the end of the first cardioplegia
|
|
Correlation between superior mesenteric artery mean blood velocity and laboratory parameters (arterial lactate)
Time Frame: CPB 30 min: during CPB, 30 minutes after the end of the first cardioplegia
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and arterial lactate (mmol/L)
|
CPB 30 min: during CPB, 30 minutes after the end of the first cardioplegia
|
|
Correlation between superior mesenteric artery mean blood velocity and laboratory parameters (arterial lactate)
Time Frame: CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
|
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and arterial lactate (mmol/L)
|
CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
|
|
Correlation between right renal artery mean blood velocity values during CPB and Acute Kidney Injury (AKI)
Time Frame: CPB 5 min: during CPB, 5 minutes after the end of the first cardioplegia
|
Comparison between right renal artery mean blood velocity (cm/sec) measured during CPB in patients who develop AKI according Kidney Disease Improving Global Outcomes (KDIGO) definition (AKI group) and in patients who don't develop AKI (non AKI group) during the postoperative period
|
CPB 5 min: during CPB, 5 minutes after the end of the first cardioplegia
|
|
Correlation between right renal artery mean blood velocity values during CPB and Acute Kidney Injury (AKI)
Time Frame: CPB 30 min: during CPB, 30 minutes after the end of the first cardioplegia
|
Comparison between right renal artery mean blood velocity (cm/sec) measured during CPB in patients who develop AKI according KDIGO definition (AKI group) and in patients who don't develop AKI (non AKI group) during the postoperative period
|
CPB 30 min: during CPB, 30 minutes after the end of the first cardioplegia
|
|
Correlation between right renal artery mean blood velocity values during CPB and Acute Kidney Injury (AKI)
Time Frame: CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
|
Comparison between right renal artery mean blood velocity (cm/sec) measured during CPB in patients who develop AKI according KDIGO definition (AKI group) and in patients who don't develop AKI (non AKI group) during the postoperative period
|
CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
|
|
Evaluation of serum Cystatin C in low right renal artery mean blood velocity during CPB
Time Frame: Postoperative day 1: 24 hours after the end of the cardiopulmonary by-pass
|
Comparison between serum Cystatin C mean level (mg/L) measured in patients with low (below the 25th percentile) and in patients with higher (above 25th percentile) right renal artery blood velocity (cm/sec) measured during CPB
|
Postoperative day 1: 24 hours after the end of the cardiopulmonary by-pass
|
|
Evaluation of urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL) in low right renal artery mean blood velocity
Time Frame: Immediate postoperative period: 4 hours after the end of the cardiopulmonary by-pass
|
Comparison between urinary uNGAL mean level (ng/ml) measured immediately after surgery in patients with low (below the 25th percentile) and in patients with higher (above 25th percentile) right renal artery blood velocity (cm/sec) during CPB
|
Immediate postoperative period: 4 hours after the end of the cardiopulmonary by-pass
|
|
Evaluation of urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL) in low right renal artery mean blood velocity
Time Frame: Postoperative day 1: 24 hours after the end of the cardiopulmonary by-pass
|
Comparison between urinary uNGAL mean level (ng/ml) measured on the first postoperative day in patients with low (below the 25th percentile) and in patients with higher (above 25th percentile) right renal artery blood velocity (cm/sec) during CPB
|
Postoperative day 1: 24 hours after the end of the cardiopulmonary by-pass
|
|
Evaluation of lactate in patients with low superior mesenteric artery mean blood velocity values
Time Frame: Immediate postoperative period: 4 hours after the end of the cardiopulmonary by-pass
|
Comparison between mean arterial lactate (mmol/L) measured immediately after surgery in patients with low (below the 25th percentile) and in patients with higher (above 25th percentile) superior mesenteric artery blood velocity (cm/sec) during CPB
|
Immediate postoperative period: 4 hours after the end of the cardiopulmonary by-pass
|
|
Evaluation of lactate in patients with low superior mesenteric artery mean blood velocity
Time Frame: Postoperative day 1: 24 hours after the end of the cardiopulmonary by-pass
|
Comparison between arterial lactate (mmol/L) measured on the first postoperative day in patients with low (below the 25th percentile) and in patients with higher (above 25th percentile) superior mesenteric artery mean blood velocity (cm/sec) measured during CPB
|
Postoperative day 1: 24 hours after the end of the cardiopulmonary by-pass
|
|
Evaluation of amylase in low superior mesenteric artery mean blood velocity
Time Frame: Immediate postoperative period: 4 hours after the end of the cardiopulmonary by-pass
|
Comparison between mean serum amylase (UI/L) measured immediately after surgery in patients with low (below the 25th percentile) and in patients with higher (above 25th percentile) superior mesenteric artery blood velocity (cm/sec) measured during CPB
|
Immediate postoperative period: 4 hours after the end of the cardiopulmonary by-pass
|
|
Evaluation of amylase in low superior mesenteric artery mean blood velocity
Time Frame: Postoperative day 1: 24 hours after the end of the cardiopulmonary by-pass
|
Comparison between mean serum amylase (UI/L) measured on the first postoperative day in patients with low (below the 25th percentile) and in patients with higher (above 25th percentile) superior mesenteric artery blood velocity (cm/sec) measured during CPB
|
Postoperative day 1: 24 hours after the end of the cardiopulmonary by-pass
|
|
Feasibility of measurement of right renal artery blood velocity during CPB
Time Frame: During CPB
|
the number of patients in whom is possible to measure right renal artery blood velocity during CPB
|
During CPB
|
|
Feasibility of measurement of superior mesenteric artery blood velocity during CPB
Time Frame: During CPB
|
the number of patients in whom is possible to measure superior mesenteric artery blood velocity during CPB
|
During CPB
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Cavaliere Franco, M.D., Fondazione Policlinico Agostino Gemelli IRRCS
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urogenital Diseases
- Male Urogenital Diseases
- Kidney Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Renal Insufficiency
- Acute Kidney Injury
- Diagnostic Techniques and Procedures
- Diagnosis
- Diagnostic Imaging
- Diagnostic Techniques, Cardiovascular
- Heart Function Tests
- Echocardiography
- Cardiac Imaging Techniques
- Ultrasonography
- Echocardiography, Transesophageal
Other Study ID Numbers
Other Study ID Numbers
- 4708
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Surgical Procedure
-
NCT00555243CompletedSurgical Procedure, Unspecified | Surgical Simulation
-
NCT03681990CompletedSurgical Procedure, Unspecified | Surgical Skin Preparation
-
NCT01757704CompletedComplication of Surgical Procedure
-
NCT06873347RecruitingSurgical Procedure, Unspecified
-
NCT04014647SuspendedVascular Surgical Procedure
-
NCT05421117CompletedSurgical Procedure, Unspecified
-
NCT04850885CompletedOral Surgical Procedure
-
NCT03790930UnknownSurgical Procedure, Unspecified
Clinical Trials on transesophageal echocardiogram
-
NCT04194502CompletedCongenital Heart Disease
-
NCT02661529CompletedBidirectional Cardiovascular Shunt
-
NCT06420895Active, not recruitingHeart Valve Diseases | Aortic Insufficiency
-
NCT01050361CompletedCardiovascular Risk Factors
-
NCT03922178Completed
-
NCT02453451Unknown
-
NCT02814851Completed
-
NCT06672315RecruitingOut-of-hospital Cardiac Arrest (OHCA)
-
NCT06178471Not yet recruiting
-
NCT03331029UnknownComparison of 3D Monitored Changes of Left Atrial Volume Before and After Ablation With Conventional Transesophageal Echocardiography